Repurposed anticancer agent becomes sound-activated antibacterial drug candidate
Researchers have developed a new antibacterial drug candidate by repurposing an anticancer agent that uses ruthenium. The drug is activated by ultrasound, allowing it to penetrate deep into tissues to combat bacterial infections.
Why it matters
This innovation offers a potential breakthrough in treating deep-tissue infections, addressing the growing global challenge of antibiotic resistance.
Sorry but it looks as if your browser is out of date. To get the best experience using our site we recommend that you upgrade or switch browsers.
The article is a technical report on scientific research with no political or social bias.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in